Chunmei Wen

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Jie Deng · 4 shared papers, 2022–2025 · strength 0.73
   • Paper Formosanin C Induces ROS/p38-Mediated Cell Death While Also Promoting Protective Autophagy in Pancreatic Cancer. DOI 10.1002/ptr.70094↗
   • Paper Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity. DOI 10.1016/j.phymed.2023.154990↗
   • Paper Corynoxine suppresses pancreatic cancer growth primarily via ROS-p38 mediated cytostatic effects. DOI 10.1038/s41416-022-02002-2↗
2. Qingqing Ruan · 4 shared papers, 2022–2025 · strength 0.73
   • Paper Formosanin C Induces ROS/p38-Mediated Cell Death While Also Promoting Protective Autophagy in Pancreatic Cancer. DOI 10.1002/ptr.70094↗
   • Paper Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity. DOI 10.1016/j.phymed.2023.154990↗
   • Paper Corynoxine suppresses pancreatic cancer growth primarily via ROS-p38 mediated cytostatic effects. DOI 10.1038/s41416-022-02002-2↗
3. Yongheng Bai · 2 shared papers, 2022–2023 · strength 0.32
   • Paper Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity. DOI 10.1016/j.phymed.2023.154990↗
   • Paper Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling. DOI 10.1016/j.phymed.2021.153861↗
4. Ni Xie · 1 shared paper, 2025 · strength 0.25
   • Paper Formosanin C Induces ROS/p38-Mediated Cell Death While Also Promoting Protective Autophagy in Pancreatic Cancer. DOI 10.1002/ptr.70094↗
5. Deyuan Chen · 1 shared paper, 2025 · strength 0.25
   • Paper Formosanin C Induces ROS/p38-Mediated Cell Death While Also Promoting Protective Autophagy in Pancreatic Cancer. DOI 10.1002/ptr.70094↗
6. Guogang Li · 1 shared paper, 2023 · strength 0.18
   • Paper Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity. DOI 10.1016/j.phymed.2023.154990↗
7. Guihua Jin · 1 shared paper, 2023 · strength 0.18
   • Paper Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity. DOI 10.1016/j.phymed.2023.154990↗
8. Xiang Zhou · 1 shared paper, 2022 · strength 0.16
   • Paper Corynoxine suppresses pancreatic cancer growth primarily via ROS-p38 mediated cytostatic effects. DOI 10.1038/s41416-022-02002-2↗
9. Zheng Xu · 1 shared paper, 2022 · strength 0.16
   • Paper Corynoxine suppresses pancreatic cancer growth primarily via ROS-p38 mediated cytostatic effects. DOI 10.1038/s41416-022-02002-2↗
10. Percy David Papa Akuetteh · 1 shared paper, 2022 · strength 0.16
    • Paper Corynoxine suppresses pancreatic cancer growth primarily via ROS-p38 mediated cytostatic effects. DOI 10.1038/s41416-022-02002-2↗
11. Xu Zheng · 1 shared paper, 2022 · strength 0.15
    • Paper Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling. DOI 10.1016/j.phymed.2021.153861↗
12. Xiang Zhou · 1 shared paper, 2022 · strength 0.15
    • Paper Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling. DOI 10.1016/j.phymed.2021.153861↗
13. Wei‐Ming Wang · 1 shared paper, 2022 · strength 0.15
    • Paper Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling. DOI 10.1016/j.phymed.2021.153861↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.